AbbVie has a deep heritage in oncology research. Our methodologies to
advance cancer treatment are becoming foundational to the next
generation of cancer treatment. We research, validate and target
specific molecular pathways, allowing us to discover and develop
innovative cancer therapies that aim to disrupt the natural
progression of cancer cells. Our efforts combine a deep understanding
of how cancer works with state-of-the-art technologies to deliver
smarter solutions faster.
As a global biopharmaceutical company, our development process begins
with the patient. Our efforts are focused on cancers with a
significant unmet medical need. AbbVie is currently evaluating 16
compounds in more than 200+ active clinical trials in various settings
around the world as potential treatment options for 20+ types of cancer.
To help cancer patients, we focus on innovation: identifying ways to
streamline the R&D process and investing in technologies and
approaches that help us to advance the delivery of promising
treatments. Additionally, we are designing adaptive clinical trials,
which help us to more rapidly establish proof of concept and determine
the appropriate dose of an investigational medicine—making our
clinical trials smarter, faster and more efficient.
We are also
focusing on new methods, such as biochemical markers, imaging
technologies and the use of definitive, clinical endpoints, which may
help us more quickly evaluate the effectiveness of our oncology compounds.
Four of our world-class research facilities have a strong focus in
oncology, where researchers work to discover and develop medicines
that will make a transformational improvement in cancer treatment.
Each location brings leadership in distinct areas of oncology research
– from core biologies like apoptosis, DNA damage, cancer stem cells
and immuno-oncology, to cutting-edge technologies like antibody drug
conjugates (ADC), DVD/bispecifics and cell-based therapies.
Oncology R&D Centers:
Lake County, Illinois
Redwood City, California
South San Francisco,
California: formerly Stemcentrx
California: home to Pharmacyclics LLC,
an AbbVie Company